OssDsign’s latest investor presentation and CEO-interview now available

OssDsign AB (publ) (“OssDsign” or the ”Company”) makes available the latest investor presentation from ProHearings as well as an interview with CEO Anders Lundqvist held during Erik Penser Bolagsdag. 

In parallel to the publication of the third quarter results OssDsign presented for investors at ProHearing on September 29th as well as at Erik Penser Bolagsdag on November 27th. Both the ProHearings investor presentation as well as a CEO-interview held during Erik Penser Bolagsdag are now available on OssDsigns website  www.ossdsign.com/presentations together with previous presentations and interviews (in Swedish).

OssDsign will also be presenting at BioStock Live Sthlm on December 3d. För more information och registration go to www.eventbrite.com.

For further information, please contact:
Anders Lundqvist, CEO, OssDsign AB
Tel: +46 73 206 98 08, email: al@ossdsign.com

Certified Adviser
The Company’s Certified Adviser is Erik Penser Bank AB. Contact information: Erik Penser Bank AB, Box 7405, 103 91 Stockholm, Sweden, phone: +46 (0)8-463 80 00, email: certifiedadviser@penser.se.

About OssDsign
OssDsign is a Swedish medical technology company that develops and manufactures regenerative implants for improved healing of bone defects. Providing neuro and plastic surgeons with innovative implants, OssDsign improves the outcome for patients with severe cranial and facial defects worldwide. By combining clinical knowledge with proprietary technology, OssDsign manufactures and sells a growing range of patient-specific solutions for treating cranial defects and facial reconstruction. OssDsign's technology is the result of collaboration between clinical researchers at Karolinska University Hospital in Stockholm and material scientists at the Ångström Laboratory at Uppsala University.

About Us

OssDsign is a Swedish medical technology company that develops and manufactures regenerative implants for improved healing of bone defects. Providing neuro and plastic surgeons with innovative implants, OssDsign improves the outcome for patients with severe cranial and facial defects worldwide. By combining clinical knowledge with proprietary technology, OssDsign manufactures and sells a growing range of patient-specific solutions for treating cranial defects and facial reconstruction. OssDsign's technology is the result of collaboration between clinical researchers at Karolinska University Hospital in Stockholm and material scientists at the Ångström Laboratory at Uppsala University.

Subscribe

Documents & Links